Angiontyo tnas are found with some freq uency in the f ema le ge nital tract. They can also app ea r in bot h sexes in the gastrointe stinal tract and in the skin. The oral cavity is an unu sual site f or an angio myoma. In this article, we describe the case of a 74-yea r-old woman who came to us with a nodule at the palatal midline. Foll owing surg ical excision of the growth and stent pl acement over the wound site, a biopsy analysis was p erform ed. Histology of the removed tissue revealed all unusual variant of all angiomyoma: a myx oid angiom yotna.
Introduction
Leiomyom as (benign smooth-muscle tum ors) occ ur most ofte n in the fema le ge nital tract as the so-called uterille fib roid. Th ese tumo rs can also app ear in the gas trointestinal tract and in the skin in both sexes. Leiomy om as can be classified as one of thre e typ es: so lid , epithe lioid (leiomyobl astom a), and vascular (ang iomyo ma or ang ioleiomyom a).' An unu sual variant of the angiomyomathe myxoid angiomyo ma-has been descr ibed by Enzinger and We iss.?Angiomyomas are not usually see n in the oral cav ity. In this article, we repo rt a case of a pal atal lesion that was histologically identifie d as a mixed angiomyo ma .
Case report
During a regul arl y scheduled prophylactic dental appointment , a whit e 74-year-old wom an ex pressed con-cern about a palatal mass. She had first not iced the mass approxi mately 6 weeks earlier.
Accordi ng to her medical history, she had been diagnosed with carci no ma in situ of the cervix 9 yea rs earlier, and she had und ergone a complete hysterectom y with oophorec to my at that tim e. Seven years later , a benign sebaceous cyst was rem oved from the midline of her left breast. She had also undergone several excisio ns of basal ce ll carcino mas fro m her midface over the precedin g 35 years, most recentl y the removal of a lesion from the left ala 4 years earlier. She also had a 50-year history of smoking one pack of cigarettes per day and mild social alco hol intake.
Intraoral examination revea led the presence of a I-cm soft-tissue mass that involved the midlin e of the hard palate 2.6 em poste rior to the incisive pap illa. Th e lesion felt firm and had an erythematous surface that featured an ulc erated ce nter and rolled borders (figure J). No other intrao ral abnorma lity was observed. Peri oral exa mination failed to reveal any lymphadenopath y or other abnormality.
An algi nate imp ression was made of the max illa to establish a presu rgical record. The surgic al team was able to alter the result ing cast afte r recont ouring the palate. The cast also allowed for the fabricatio n of the surgical stent that would cover the surgica l site by engag ing the undercut s of the maxill ary teeth for retenti on , much like a maxillary ortho do ntic ret ainer (figure 2). Th is pro cedure was foll owed by an exci sio nal biop sy of the lesion under local anesthesia. Fo llow ing the removal of the nodul e, the prefabr icated acry lic stent was secure d in place. The surgeons felt that suturing was not indicated becau se the stent allow ed for tissue adaptatio n of the surg ical site and provided a template for wound healing by secondary intenti on . As a prec autionary measure follow ing the excision of the lesion , the pat ient was started on penicillin for 5 days and given acet amin oph en for ana lges ia. No post- Rat Hepatocyt e DNARepair Assay Mi cronucleus Test (Mice) Dominant Lethal Test (Mice) Long-termcarcinoge nicitystudies in miceand rats have beencompleted for clprotloxacin. After daily oral doses of 750 mglkg (mice) and 250mglkg (rats) wereadmi nistered for up to 2 years,therewas noevidencethat ci profloxacin had anycarcinogenic or tumorigenic effects in these species. No longtermstudies of CIPRO' HCOTICsuspension havebeen pertormedto evaluatecarcinogenicpoten tial. Fert ility studies pertormed in rats at oral doses of ciprofloxaci n up to 100 mglkg/day revealed no evidence of impairment. This would beover 1000 times the maximum recommended cl inical dose of ototopical ciprofloxacln based uponbody surtacearea, assumingtotalabsorpt ionof ci prof loxacinfromthe ear of a patient treatedwith CI PRO' HCOTICtwi ceper day. Long term studies have not been perf ormed to evaluate the carcinogenic potential or the effect on ferti lityoftopica l hydroco rtisone, Mutagenicitystudies with hydrocortisonewere negative. Pregnancy:TeratogenicEIIects, Pregnancy CategoryC: Reproduction studies have been pertormed in ratsand mice using oraldoses of upto 100 mglkgandIV doses upto 30 mglkgand have revealed no evidence of harm to thetetus asa resul t 01 ci profloxacin. In rabbits, ci profloxacin (30and100mglkgorally)producedgastrointestinal disturbances resultingin maternalweig htloss andan increased incidenceot abortion, butno terafogenicity was observed at eit her dose. After intravenousadministrat ionofdoses upto20 mglkg, no maternaltoxi city was produced inthe rabbi t, and noembryotoxicityor teratogeni city was observed. Corticosteroids are generally feratogenic in laboratory animals when administered systemically at relat ively low dosage levels. The more potent corticosteroi ds have been shown to be teratogenic after dermal applicafion in laborat oryanimals. Animal reproduction studies have not been conducted with CIPRO' HC OTIC. No adeq uate and well controll ed studies have been pert ormed in pregnant women. Caution should be exercised when CI PRO' HCOTICis usedby a pregnantwoma n. Nursing Mothers: Ciprofloxacin is excreted in humanmil k with systemicuse. It is not known whether ciprofloxacin is excreted in humanmilk followi ng topical oticadministration. 8ecause of thepotential for ser iousadverse reactions in nursinginfant s, adecisionshould bemadewhether to discontinue nursingor to discontinuethedrug, takingintoaccount theimportance 01thedrugtothe mother. Pediafric use: The safety and efficacy of CIPRO' HC OTI C have been established in pediatric patlents 2 years and older (131 patient s) in adeq uate and well-controlled cl inical trials. Although no dat a are available on patients less than age 2 years, there are no know n safety concerns or differences in the diseaseprocessinthispopulation which would preclude useof thi s product inpat ients one year and older. operative compl ica tion s were encoun tered, and the excision site healed complete ly within 4 week s. Histopatho logic examination of the lesion ide ntified a fair ly well circ um scribed myxomatous ma ss covered with a partially ulcerated mucosal epithelium (figure 3, A) . Prominent vascular ity was associated wit h the myxomato us tissue. So me neural structures we re also observed. A proliferat ion of smooth muscle associ ated with the vascular wa lls wa s apparent. The nature of the smoo th-mu scle proli feratio n was accentuated by trichrome staining (figure 3, B) . At 4 years, there was no recurrence, and the patient was main tained on a regu lar recall schedule for eva luation.
Discu ss ion
Smooth-m uscle neop lasm s (leiomyomas and angiomyomas) of the ora l muc osa are we ll recognized and have been describ ed in the literature.r" The histologically my xoid variant of angiomyoma is far less common and has not been reported in the ora l cavity as a d istin ct entity. Ora l leiomyomas with myxoid change, however , have been described. ' Th e cli nica l diagnosis of a leiomyoma or an angiomyoma is difficult, if not impo ssible, because there are no disti nct ive clinical features ass oc iated with these tumors; they are usually asymptomatic and hav e the color of The histologic differen tial diagnosis in this case included a nerve sheath myxoma and a neurofibroma with myxomatous change, in addition to the myxoid angiomyoma. Enzinger and Weiss reported that the differential diagnosis co uld also inc lude nodular fasc iitis and myxoma .' The diagnosis ofmyxoid angiomyoma is made considerably easier by histochemical staining-specifically the trichrome stain. Staining biopsy samples with Masson ' s trichrome shows smoo th-muscle cells as red , and collagen in various shades from blue to gree n." This is how our samples staine d, and it enab led us to establish the diagnosis.
Although myxoid changes in soft-tissue tumors are well recognized, they are not always clearly understood. Trauma and the duration of pressure have bee n sugges ted as two possi ble etio logic factors in myxomatous dise ase, altho ugh this is pure ly spec ulative. Traum a was noted in our patien t, but the duration of press ure was relative ly short (6 wk) .
Angiomyomas are trea ted by surgical excision. Recurrences and malignant changes are not common. As always , it is best to examine and iden tify any abnormality of the ora l cavity. Eve n though myxoid angiomyomas rarely ex hibit malignant changes, malignancy must still be ruled out.
Our patie nt had a surgical stent placed po stoperatively to aid in the healing of the surgical site. In addition to the mechanical appro xima tio n of the tissue follow ing the excision of a lesion, a stent also ( 1) keeps the patient more comfor table by pro tecting the wo und from mec hanical trauma and loca l irritation, (2) preve nts the formation of IE "' · Figure 3 . A : Histolo gic specimen at low-p ower ma gnifica tion illustrates the well-circ umscribed border of the lesion, whi ch contains bundles of muscle fib ers and blood vessels. B: Highpower ma gnification of the myxoid angioniyonia with trichrome staining reveals a pro liferation of sm ooth muscles and niyxo id stroma. exuberant granulation tissue, and (3) acts as a temp late for the wo und healing precess.' An ideal palatal stent sho uld not irritate the biologic tissues , sho uld not interfere with ora l functions, and should be relative ly easy to fabricate and maintain."
